Skip to main content
Top
Published in: Cancer Imaging 1/2019

Open Access 01-12-2019 | Metastasis | Research article

Distribution of metastasis in the brain in relation to the hippocampus: a retrospective single-center analysis of 565 metastases in 116 patients

Authors: Qian Sun, Min Li, Gengming Wang, Hongbo Xu, Zelai He, Yongchun Zhou, Yan Zhou, Yufu Zhou, Hongwei Song, Hao Jiang

Published in: Cancer Imaging | Issue 1/2019

Login to get access

Abstract

Objective

To examine the distribution of brain metastases (BM) in relation to the hippocampus, so as to determine the risk of metastasis in the hippocampus, and thus provide experimental evidence for the hippocampal avoidance (HA) in patients with BM during radiotherapy.

Methods

(1) For the retrospective analysis of 116 patients diagnosed with malignancies, confirmed as BM, from December 2014 to December 2016 at the First Affiliated Hospital of Bengbu Medical College. We obtained the T1-weighted, postcontrast axial, sagittal, and coronal Magnetic Resonance imaging (MRI) images f the patients, in supine position, using the head restraints and head thermoplastic masks to adjust the positioning, with computed tomography (CT) positioning scan ranging from the head to the mandible (layer thickness: 3 mm). CT and MRI images were fused on a Philips Pinnacle v9.8 treatment planning system;(2) Every metastasis of the 565 metastases was contoured;(3) hippocampus were contoured, and hippocampus with 5 mm expansion envelopes were analyzed;(4) Using the SPSS 16.0 software, we analyzed the relation between the distribution and age, sex, Karnofsky performance status (KPS), primary site, aggregate volume of intracranial metastases and the whole brain. The data were analyzed using a binary logistic regression analysis method, with two-sided P < 0.05 for statistical significance.

Results

In this study, we recruited 116 patients with 565 metastases. Among them, 1.7% (n = 2) had metastases in the hippocampus, and 11.2% (n = 13) had metastases within 5 mm of the hippocampus, of which more than half were patients with non-small cell lung cancer (n = 7). Using a binary logistic regression to analyze the relation between the metastases located within 5 mm of the hippocampus and age (P = 0.395), sex (P = 0.139), KPS (P = 0.724), primary site (P = 0.894), aggregate volume of intracranial metastases (p = 0.093) and the whole brain (p = 0.998), and none of them showed statistically significant difference between them and the metastases location (P>0.05).

Conclusion

This study showed a low risk for the perihippocampal metastases (PHM) and no significant correlation between PHM and age, sex, KPS, primary site, aggregate volume of intracranial metastases and the whole brain. Accordingly, it is may be acceptable to avoid the perihippocampal region during whole brain radiotherapy.
Literature
1.
go back to reference Goni V, Tome WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol. 2010;97:370–6.CrossRef Goni V, Tome WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol. 2010;97:370–6.CrossRef
2.
go back to reference Vinai G, Hermann BP, Mehta MP, et al. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Rad Onco. 2013;85(2):348–54.CrossRef Vinai G, Hermann BP, Mehta MP, et al. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Rad Onco. 2013;85(2):348–54.CrossRef
3.
go back to reference Chargari C, Campana F, Pierga JY, et al. Whole-brain radiation therapy in breast cancer patients with brain metastases. Nat Rev Clin Oncol. 2010;7:632–40.CrossRef Chargari C, Campana F, Pierga JY, et al. Whole-brain radiation therapy in breast cancer patients with brain metastases. Nat Rev Clin Oncol. 2010;7:632–40.CrossRef
4.
go back to reference Armstrong GT, Reddick WE, Petersen RC, et al. Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst. 2013;105(12):899–907.CrossRef Armstrong GT, Reddick WE, Petersen RC, et al. Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst. 2013;105(12):899–907.CrossRef
5.
go back to reference Milner B, Penfield W. The effect of hippocampal lesions on recent memory [J]. Trans Am Neurol Assoc. 1955, 80th Meeting: 42–48. Milner B, Penfield W. The effect of hippocampal lesions on recent memory [J]. Trans Am Neurol Assoc. 1955, 80th Meeting: 42–48.
6.
go back to reference Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933):a phaseIImulti-institutional trial. J Clin Oncol. 2014;32(34):3810–6.CrossRef Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933):a phaseIImulti-institutional trial. J Clin Oncol. 2014;32(34):3810–6.CrossRef
7.
go back to reference Milner B, Klein D. Loss of recent memory after bilateral hippocampal lesions: memory and memories-looking back and looking forward. J Neurol Neurosurg Psychiatry. 2016;87(3):230.CrossRef Milner B, Klein D. Loss of recent memory after bilateral hippocampal lesions: memory and memories-looking back and looking forward. J Neurol Neurosurg Psychiatry. 2016;87(3):230.CrossRef
8.
go back to reference Pourkhodadad S, Alirezaei M, Moghaddasi M, et al. Neuroprotective effects of oleuropein against cognitive dysfunction induced by colchicine in hippocampal CA1 area in rats. J Physiol Sci. 2016;66(5):397–405.CrossRef Pourkhodadad S, Alirezaei M, Moghaddasi M, et al. Neuroprotective effects of oleuropein against cognitive dysfunction induced by colchicine in hippocampal CA1 area in rats. J Physiol Sci. 2016;66(5):397–405.CrossRef
9.
go back to reference Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037–44.CrossRef Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037–44.CrossRef
10.
go back to reference Brown PD, Jaeckle K, Ballman KV, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016;16(4):401–9.CrossRef Brown PD, Jaeckle K, Ballman KV, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016;16(4):401–9.CrossRef
11.
go back to reference Owonikoko TK, Arbiser J, Zelnak A, et al. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014;11(4):203–22.CrossRef Owonikoko TK, Arbiser J, Zelnak A, et al. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014;11(4):203–22.CrossRef
12.
go back to reference Wikman H, Westphal L, Schmid F, et al. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients. Oncotarget. 2014;5(10):3076–87.CrossRef Wikman H, Westphal L, Schmid F, et al. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients. Oncotarget. 2014;5(10):3076–87.CrossRef
13.
go back to reference Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brainmetastases:a systematic review and evidence-based clinical practice guideline. J Neuro Oncol. 2010;96(1):45–68.CrossRef Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brainmetastases:a systematic review and evidence-based clinical practice guideline. J Neuro Oncol. 2010;96(1):45–68.CrossRef
14.
go back to reference Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain:a randomized trail. J Am Med Assoc. 1998;280(17):1485–9.CrossRef Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain:a randomized trail. J Am Med Assoc. 1998;280(17):1485–9.CrossRef
15.
go back to reference Soffietti R, Kocher M, Abacioglu UM, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant wholebrain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31(1):65–72.CrossRef Soffietti R, Kocher M, Abacioglu UM, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant wholebrain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31(1):65–72.CrossRef
16.
go back to reference Harth S, Abo-Madyan Y, Zheng L, et al. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol. 2013;109(1):152–8.CrossRef Harth S, Abo-Madyan Y, Zheng L, et al. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol. 2013;109(1):152–8.CrossRef
17.
go back to reference Wan JF, Zhang SJ, Wang L, et al. Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270 metastases in 488 patients. J Radiat Res. 2013;54(2):285–91.CrossRef Wan JF, Zhang SJ, Wang L, et al. Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270 metastases in 488 patients. J Radiat Res. 2013;54(2):285–91.CrossRef
18.
go back to reference Andrews DW, Scott CB, Sperduto RW, et al. Whole brain radio therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases :phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363(9422):1665–72.CrossRef Andrews DW, Scott CB, Sperduto RW, et al. Whole brain radio therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases :phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363(9422):1665–72.CrossRef
19.
go back to reference Ghia A, Tome WA, Thomas S, et al. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys. 2007;68(4):971–7.CrossRef Ghia A, Tome WA, Thomas S, et al. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys. 2007;68(4):971–7.CrossRef
20.
go back to reference Gondi V, Tolakanahalli R, Mehta MP, et al. Hippocampal-sparing whole-brain radiotherapy:a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(4):1244–52.CrossRef Gondi V, Tolakanahalli R, Mehta MP, et al. Hippocampal-sparing whole-brain radiotherapy:a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(4):1244–52.CrossRef
21.
go back to reference Mueller RP, Soffietti R, Abaciouglu MU, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1–3 cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol. 2009;27:561–6. Mueller RP, Soffietti R, Abaciouglu MU, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1–3 cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol. 2009;27:561–6.
22.
go back to reference Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010;65(1):7–19.CrossRef Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010;65(1):7–19.CrossRef
23.
go back to reference Shao Q, Liu SS, Wang W, et al. Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer. OncoTargets and Therapy. 2017;10:535–41.CrossRef Shao Q, Liu SS, Wang W, et al. Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer. OncoTargets and Therapy. 2017;10:535–41.CrossRef
24.
go back to reference Gondi V, Tome WA, Marsh J, et al. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol. 2010;95(3):327–31.CrossRef Gondi V, Tome WA, Marsh J, et al. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol. 2010;95(3):327–31.CrossRef
25.
go back to reference Wu SG, Rao MY, Zhou J, et al. Distribution of metastatic disease in the brain in relation to the hippocampus: a retrospective single-center analysis of 6064 metastases in 632 patients. Oncotarget. 2015;6(41):44030–6.PubMedPubMedCentral Wu SG, Rao MY, Zhou J, et al. Distribution of metastatic disease in the brain in relation to the hippocampus: a retrospective single-center analysis of 6064 metastases in 632 patients. Oncotarget. 2015;6(41):44030–6.PubMedPubMedCentral
26.
go back to reference Wiksyk B, Nguyen DH, Alexander C, et al. Population-based analysis of treatment and survival in women presenting with brain metastasis at initial breast Cancer diagnosis. Am J Clin Oncol. 2016;39(3):255–60.CrossRef Wiksyk B, Nguyen DH, Alexander C, et al. Population-based analysis of treatment and survival in women presenting with brain metastasis at initial breast Cancer diagnosis. Am J Clin Oncol. 2016;39(3):255–60.CrossRef
27.
go back to reference McDonald MW, McMullen KP. A new paradigm in treatment of brain metastases. Curr Probl Cancer. 2015;39(2):70–88.CrossRef McDonald MW, McMullen KP. A new paradigm in treatment of brain metastases. Curr Probl Cancer. 2015;39(2):70–88.CrossRef
28.
go back to reference Malmström A, Grønberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma:the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13(9):916–26.CrossRef Malmström A, Grønberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma:the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13(9):916–26.CrossRef
29.
go back to reference Dawood S, Broglio K, Esteva FJ, et al. Survival among women with triple receptot-negative breast cancer and brain metastases. Ann Oncol. 2009;20(4):621–7.CrossRef Dawood S, Broglio K, Esteva FJ, et al. Survival among women with triple receptot-negative breast cancer and brain metastases. Ann Oncol. 2009;20(4):621–7.CrossRef
30.
go back to reference Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004;22(17):3608–17.CrossRef Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004;22(17):3608–17.CrossRef
31.
go back to reference Wu SG, Sun JY, Tong Q, et al. Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy. Ther Clin Risk Manag. 2016;12:1849–53.CrossRef Wu SG, Sun JY, Tong Q, et al. Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy. Ther Clin Risk Manag. 2016;12:1849–53.CrossRef
32.
go back to reference Silvia N, Valentina B, Silvia N. Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. Transl Lung Cancer Res. 2016;5(6):610–27.CrossRef Silvia N, Valentina B, Silvia N. Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. Transl Lung Cancer Res. 2016;5(6):610–27.CrossRef
33.
go back to reference Gondi V, Tome WA, Mehta MP. Why avoid the Hippocampus? A Comprehensive Review Radiother Oncol. 2010;97(3):370–6.CrossRef Gondi V, Tome WA, Mehta MP. Why avoid the Hippocampus? A Comprehensive Review Radiother Oncol. 2010;97(3):370–6.CrossRef
34.
go back to reference Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol. 2005;23(24):5511–9.CrossRef Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol. 2005;23(24):5511–9.CrossRef
35.
go back to reference Roughton K, Kalm M, Blomgren K, et al. Sex-dependent differences in behavior and hippocampal neurogenesis after irradiation to the young mouse brain. Eur J Neurosci. 2012;36(6):2763–72.CrossRef Roughton K, Kalm M, Blomgren K, et al. Sex-dependent differences in behavior and hippocampal neurogenesis after irradiation to the young mouse brain. Eur J Neurosci. 2012;36(6):2763–72.CrossRef
Metadata
Title
Distribution of metastasis in the brain in relation to the hippocampus: a retrospective single-center analysis of 565 metastases in 116 patients
Authors
Qian Sun
Min Li
Gengming Wang
Hongbo Xu
Zelai He
Yongchun Zhou
Yan Zhou
Yufu Zhou
Hongwei Song
Hao Jiang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2019
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-019-0188-6

Other articles of this Issue 1/2019

Cancer Imaging 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine